J. Scott Garland - Oct 16, 2023 Form 3 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
Director
Signature
/s/ Shane Kovacs, Attorney-in-Fact
Stock symbol
OLMA
Transactions as of
Oct 16, 2023
Transactions value $
$0
Form type
3
Date filed
10/17/2023, 04:42 PM
Previous filing
Jun 26, 2023
Next filing
May 28, 2024

No securities are beneficially owned.